Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
11
NMPA:11
Drug Approvals
Entecavir oral solution
- Product Name
- 恩替卡韦口服溶液
- Approval Number
- 国药准字H20253587
- Approval Date
- Mar 11, 2025
NMPA
Levetiracetam in sodium chloride injection
- Product Name
- 左乙拉西坦氯化钠注射液
- Approval Number
- 国药准字H20253254
- Approval Date
- Jan 24, 2025
NMPA
Desloratadine oral solution
- Product Name
- 地氯雷他定口服溶液
- Approval Number
- 国药准字H20233919
- Approval Date
- Oct 15, 2024
NMPA
Levetiracetam Oral Solution
- Product Name
- 左乙拉西坦口服溶液
- Approval Number
- 国药准字H20244954
- Approval Date
- Sep 19, 2024
NMPA
Gemcitabine Hydrochloride for Injection
- Product Name
- 注射用盐酸吉西他滨
- Approval Number
- 国药准字H20244270
- Approval Date
- Jun 28, 2024
NMPA
Gemcitabine Hydrochloride for Injection
- Product Name
- 注射用盐酸吉西他滨
- Approval Number
- 国药准字H20244269
- Approval Date
- Jun 28, 2024
NMPA
Palonosetron Hydrochloride Injection
- Product Name
- 盐酸帕洛诺司琼注射液
- Approval Number
- 国药准字H20244107
- Approval Date
- Jun 25, 2024
NMPA
Palonosetron Hydrochloride Injection
- Product Name
- 盐酸帕洛诺司琼注射液
- Approval Number
- 国药准字H20244106
- Approval Date
- Jun 25, 2024
NMPA
Moxifloxacin Hydrochloride and Sodium Chloride Injection
- Product Name
- 盐酸莫西沙星氯化钠注射液
- Approval Number
- 国药准字H20243201
- Approval Date
- Feb 23, 2024
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found